PT-141, or Bremelanotide, has been a sexual health revolution. Medical professionals investigated the unintended side effect of an increase in sexual desire for PT-141, which was designed as a tanning agent from Melanotan II.
This medication does not work like most of the treatments available for sexual dysfunction, which increases genital blood flow; instead, it activates melanocortin receptors in the brain. This new mechanism makes it very effective in the management of erectile dysfunction (ED) and female sexual arousal disorder (FSAD) and presents an exciting solution for patients who are non-responsive to other available medications.
Action Mechanism
The novel modulation mechanism of arousal differentiates PT-141 from all other drugs that have been developed for sexual dysfunction traditionally. PT-141 also releases oxytocin, which assists in social bonding and reproduction. For that, one needs to choose the best PT 141 supplier for the quality of the product. PT-141 from the manufacturer of the product – peptide.ltd has become one of the most efficient medication tools in the treatment of sexual arousal difficulties over the vascular constraints many other drugs have.
Effectiveness and Research
More clinical studies were related to the effectiveness of PT-141. It was found that it produces sexual desire even without physical stimulation; hence, it becomes a new alternative for patients with sexual dysfunction. Clinical studies indicated that PT-141 increases arousal in males and females. Due to the wide range of applications, it is highly effective in sexual health treatment. This offers a promising alternative to those who can’t overcome psychological barriers to arousal or to whom classical drugs are ineffective; their use of PT-141 will be of great benefit.
Dosage & Administration
Proper knowledge about this Polypeptide dosage and its mode of administration will produce excellent outcomes with minimal side effects. PT-141 can generally be injected subcutaneously. The dosage varies with the patient. Laboratories prescribe the consumption of PT-141 at 0.5 to 3.0 mg 45 minutes to an hour before sexual activity. Patients must start with minimal dosages in the administration by doctors as a measure to detect any reaction and make alterations accordingly. Since the mechanism behind PT-141 is different, it gives a rapid onset time, which is often surprising intimacy the users prefer.
Production of PT-141
PT-141 was discovered and studied by many leading biotechnology companies that specialize in the production of peptide synthesis and pharmaceutical innovation. The company Palatin Technologies has been excellent to date concerning medicinal potential with PT-141 from peptide.ltd. The diversification of investment the company made in the study of the mechanisms of the peptide has helped them reach clinical trials. Palatin Technologies has done all it takes to have PT-141 approved and available to those who need it.